Abstract CT016: Abexinostat (ABX) as a means to reverse pazopanib (PAZ) resistance: a phase I study in advanced solid tumor malignancies
2018 ◽
Vol 81
(3)
◽
pp. 587-596
◽
2012 ◽
Vol 71
(3)
◽
pp. 627-633
◽
2016 ◽
Vol 34
(15_suppl)
◽
pp. 2589-2589
◽
2008 ◽
Vol 26
(15_suppl)
◽
pp. 3520-3520
◽